NO332315B1 - Bionedbrytbar biomedisinsk polyuretan med faseseparert morfologi, fremgangsmate for fremstilling derav og anvendelse derav i menisk rekonstruksjon - Google Patents
Bionedbrytbar biomedisinsk polyuretan med faseseparert morfologi, fremgangsmate for fremstilling derav og anvendelse derav i menisk rekonstruksjon Download PDFInfo
- Publication number
- NO332315B1 NO332315B1 NO20006180A NO20006180A NO332315B1 NO 332315 B1 NO332315 B1 NO 332315B1 NO 20006180 A NO20006180 A NO 20006180A NO 20006180 A NO20006180 A NO 20006180A NO 332315 B1 NO332315 B1 NO 332315B1
- Authority
- NO
- Norway
- Prior art keywords
- polyester
- polyurethane
- polyurethane according
- diisocyanate
- diol
- Prior art date
Links
- 229920002635 polyurethane Polymers 0.000 title claims abstract description 51
- 239000004814 polyurethane Substances 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims description 16
- 230000005499 meniscus Effects 0.000 title description 3
- 150000002009 diols Chemical class 0.000 claims abstract description 32
- 229920000728 polyester Polymers 0.000 claims abstract description 30
- 125000005442 diisocyanate group Chemical group 0.000 claims abstract description 16
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 20
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 15
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 15
- 229920001634 Copolyester Polymers 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000007795 chemical reaction product Substances 0.000 claims description 7
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 claims description 6
- 239000007943 implant Substances 0.000 claims description 6
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 229920000570 polyether Polymers 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 3
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical group CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 claims description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 229920005604 random copolymer Polymers 0.000 claims description 2
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims 2
- 229920002988 biodegradable polymer Polymers 0.000 claims 1
- 239000004621 biodegradable polymer Substances 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims 1
- 229920000642 polymer Polymers 0.000 abstract description 13
- 239000000463 material Substances 0.000 description 17
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 5
- 229920001577 copolymer Chemical compound 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 229920003226 polyurethane urea Polymers 0.000 description 5
- 238000005809 transesterification reaction Methods 0.000 description 5
- 239000004970 Chain extender Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 229920001610 polycaprolactone Polymers 0.000 description 4
- 239000004632 polycaprolactone Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- FDYWJVHETVDSRA-UHFFFAOYSA-N 1,1-diisocyanatobutane Chemical compound CCCC(N=C=O)N=C=O FDYWJVHETVDSRA-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000007098 aminolysis reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 210000000968 fibrocartilage Anatomy 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000007433 nerve pathway Effects 0.000 description 2
- -1 poly(e-caprolactone) Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 101100219382 Caenorhabditis elegans cah-2 gene Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- QVYARBLCAHCSFJ-UHFFFAOYSA-N butane-1,1-diamine Chemical compound CCCC(N)N QVYARBLCAHCSFJ-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/80—Masked polyisocyanates
- C08G18/8003—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen
- C08G18/8006—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32
- C08G18/8009—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32 with compounds of C08G18/3203
- C08G18/8012—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32 with compounds of C08G18/3203 with diols
- C08G18/8016—Masked aliphatic or cycloaliphatic polyisocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
- C08G18/3203—Polyhydroxy compounds
- C08G18/3206—Polyhydroxy compounds aliphatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/4269—Lactones
- C08G18/4277—Caprolactone and/or substituted caprolactone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/428—Lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/73—Polyisocyanates or polyisothiocyanates acyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2230/00—Compositions for preparing biodegradable polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Polyurethanes Or Polyureas (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98201868 | 1998-06-05 | ||
| PCT/NL1999/000352 WO1999064491A1 (en) | 1998-06-05 | 1999-06-04 | Biomedical polyurethane, its preparation and use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20006180D0 NO20006180D0 (no) | 2000-12-05 |
| NO20006180L NO20006180L (no) | 2001-01-22 |
| NO332315B1 true NO332315B1 (no) | 2012-08-27 |
Family
ID=8233784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006180A NO332315B1 (no) | 1998-06-05 | 2000-12-05 | Bionedbrytbar biomedisinsk polyuretan med faseseparert morfologi, fremgangsmate for fremstilling derav og anvendelse derav i menisk rekonstruksjon |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6784273B1 (https=) |
| EP (2) | EP1308473A1 (https=) |
| JP (1) | JP4335448B2 (https=) |
| AT (1) | ATE254636T1 (https=) |
| AU (1) | AU756740B2 (https=) |
| BR (1) | BR9910968B1 (https=) |
| CA (1) | CA2334110C (https=) |
| DE (1) | DE69912956T2 (https=) |
| ES (1) | ES2212602T3 (https=) |
| ID (1) | ID28196A (https=) |
| IL (2) | IL140049A0 (https=) |
| NO (1) | NO332315B1 (https=) |
| NZ (1) | NZ508907A (https=) |
| WO (1) | WO1999064491A1 (https=) |
| ZA (1) | ZA200007439B (https=) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE526106C2 (sv) * | 2002-06-20 | 2005-07-05 | Artimplant Ab | Linjär blockpolymer samt fiber, film, poröst material och implantat innefattande polymeren |
| EP1382628A1 (en) * | 2002-07-16 | 2004-01-21 | Polyganics B.V. | Biodegradable phase separated segmented/block co-polyesters |
| US20060216267A1 (en) * | 2002-08-20 | 2006-09-28 | Kovacs Stephen G | Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis |
| WO2004078023A2 (en) * | 2002-10-23 | 2004-09-16 | The Biomerix Corporation | Aneurysm treatment devices and methods |
| EP1581268B1 (en) | 2003-01-09 | 2011-05-04 | Polyganics B.V. | Biomedical foams |
| EP2570440A3 (en) | 2003-02-19 | 2014-06-11 | Orteq B.V. | Method for the preparation of new segmented polyurethanes with high tear and tensile strengths and method for making porous scaffolds |
| JP2007521843A (ja) | 2003-05-15 | 2007-08-09 | バイオメリクス コーポレーション | 網状化エラストマー系マトリックス、その製造、及び移植可能な装置における使用 |
| US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
| WO2006009443A1 (en) * | 2004-07-21 | 2006-01-26 | Stichting Voor De Technische Wetenschappen | Polyacylurethanes based on diisocyanates and polyesterpolyols |
| US20060135725A1 (en) * | 2004-12-21 | 2006-06-22 | Scimed Life Systems, Inc. | New balloon materials |
| JP4870071B2 (ja) * | 2005-03-18 | 2012-02-08 | 三井化学株式会社 | 生分解性を有する水環境応答型ポリマー、その製造方法および水崩壊性材料 |
| EP2066716A1 (en) * | 2006-09-29 | 2009-06-10 | Futerro S.A. | Process for producing polylactide-urethane copolymers |
| WO2008122044A2 (en) * | 2007-04-02 | 2008-10-09 | Georgia Tech Research Corporation | Implantable device for communicating with biological tissue |
| US8182647B2 (en) * | 2007-07-23 | 2012-05-22 | Cohera Medical, Inc. | Hydrophilic biodegradable adhesives |
| US20090035350A1 (en) | 2007-08-03 | 2009-02-05 | John Stankus | Polymers for implantable devices exhibiting shape-memory effects |
| US8771725B2 (en) | 2007-10-12 | 2014-07-08 | Chesson Laboratory Associates, Inc. | Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| US20090123519A1 (en) * | 2007-11-12 | 2009-05-14 | Surmodics, Inc. | Swellable hydrogel matrix and methods |
| US20090226531A1 (en) * | 2008-03-07 | 2009-09-10 | Allergan, Inc. | Methods and composition for intraocular delivery of therapeutic sirna |
| US9259515B2 (en) * | 2008-04-10 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from polyurethanes with grafted radiopaque groups |
| US20110105635A1 (en) * | 2008-05-19 | 2011-05-05 | Orteq B.V. | Polyurethane foam for use in medical implants |
| US9050176B2 (en) | 2009-04-03 | 2015-06-09 | Biomerix Corporation | At least partially resorbable reticulated elastomeric matrix elements and methods of making same |
| EP2413838A4 (en) * | 2009-04-03 | 2012-09-19 | Biomerix Corp | AT LEAST PARTIALLY RESORBIBLE RETICULATED ELASTOMER MATRIX PARTICLES AND PRODUCTION METHOD |
| US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
| GB2475778B (en) * | 2009-05-20 | 2013-03-13 | Arsenal Medical Inc | Medical implant |
| US8137396B2 (en) | 2009-05-20 | 2012-03-20 | 480 Biomedical, Inc | Medical implant |
| US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
| US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
| NL2002931C2 (en) | 2009-05-27 | 2010-11-30 | Polyganics Bv | HEMOSTATIC FOAMS. |
| GB201110601D0 (en) | 2011-06-23 | 2011-08-03 | Controlled Therapeutics Scotland Ltd | Improved bioresorbable |
| WO2013151991A1 (en) | 2012-04-02 | 2013-10-10 | Surmodics, Inc. | Hydrophilic polymeric coatings for medical articles with visualization moiety |
| WO2014159722A1 (en) * | 2013-03-12 | 2014-10-02 | Carol Livermore-Clifford | Deterministic manufacturing process for creating 3d living tissues based on 2d directed assembly and origami techniques |
| EP2842583A1 (en) | 2013-08-29 | 2015-03-04 | Ella-CS, s.r.o. | Biodegradable and bioerodible polyurethanes, method of preparation thereof and use thereof |
| WO2015087741A1 (ja) * | 2013-12-09 | 2015-06-18 | 株式会社ダイセル | ラクトン重合体の製造方法 |
| JP2018507765A (ja) | 2015-02-27 | 2018-03-22 | ポリガニクス アイピー ベーフェー | 薬物溶出発泡体及びその製造 |
| NL2016527B1 (en) * | 2016-03-31 | 2017-11-02 | Polyganics Ip B V | Tissue-adhesive biomedical materials. |
| NL2016524B1 (en) | 2016-03-31 | 2017-10-17 | Polyganics Ip B V | Tissue-adhesive material |
| NL2016526B1 (en) | 2016-03-31 | 2017-11-02 | Polyganics Ip B V | Improved biomedical polyurethanes |
| EP3670567A4 (en) * | 2017-08-17 | 2021-06-02 | Toray Industries, Inc. | POLYESTER COPOLYMER AND METHOD FOR MANUFACTURING THEREOF |
| NL2019652B1 (en) | 2017-09-29 | 2019-04-08 | Polyganics Ip B V | Tissue-adhesive sealant device |
| US10953138B2 (en) * | 2017-10-18 | 2021-03-23 | Bvw Holding Ag | Device with microstructure mediated absorption profile |
| AU2018389853B2 (en) | 2017-12-20 | 2024-10-31 | Stryker European Operations Holdings Llc | Biomedical foam |
| AU2019403377B2 (en) | 2018-12-20 | 2025-06-26 | Stryker European Operations Holdings Llc | Skull base closure systems and methods |
| NL2022710B1 (en) | 2019-03-11 | 2020-09-18 | Polyganics Ip B V | Tissue-adhesive hydrogels |
| JP7529688B2 (ja) | 2019-04-16 | 2024-08-06 | ストライカー・ユーロピアン・オペレーションズ・リミテッド | 副鼻腔ステント並びに患者の副鼻腔内でステントを展開させるシステム及び方法 |
| NL2023358B1 (en) | 2019-06-21 | 2021-02-01 | Polyganics Ip B V | Dopamine-functionalized polymers |
| CN112220968B (zh) * | 2020-12-09 | 2021-03-26 | 中国科学院化学研究所 | 一种长期替代型组织工程半月板支架的光固化3d打印制备方法 |
| IT202300012945A1 (it) * | 2023-06-22 | 2024-12-22 | G P S Tech S R L | Uso di specifici polioli poliesteri come fase soft per poliuretani facilmente degradabili e poliuretani degradabili così ottenuti |
| FR3162221A1 (fr) * | 2024-05-16 | 2025-11-21 | Arthrocart Biotech | Solide poreux biocompatible et biorésorbable pour la réalisation d’implants chirurgicaux |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE553746A (https=) * | 1955-12-27 | |||
| JPS5113879A (en) * | 1974-07-26 | 1976-02-03 | Idemitsu Kosan Co | Kaishitsutanpakuno seizohoho |
| US4284506A (en) * | 1979-12-26 | 1981-08-18 | Nl Industries, Inc. | Biomedical devices |
| NL8202894A (nl) * | 1982-07-16 | 1984-02-16 | Rijksuniversiteit | Polyesterhoudend filamentmateriaal. |
| US4543405A (en) * | 1984-10-01 | 1985-09-24 | Ppg Industries, Inc. | High solids polyurethane polyols and coating compositions thereof |
| IL82834A (en) * | 1987-06-09 | 1990-11-05 | Yissum Res Dev Co | Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom |
| NL8703115A (nl) * | 1987-12-23 | 1989-07-17 | Groningen Science Park | Biodegradeerbare polyurethanen, daarop gebaseerde voortbrengselen, en polyesterpolyol prepolymeren. |
| US4892920A (en) * | 1988-11-21 | 1990-01-09 | Air Products And Chemicals, Inc. | Process for the preparation of cyclohexanediisocyanate containing polyisocyanate prepolymers and polyurethanes having high temperature performance |
| IL90193A (en) * | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
| US5703193A (en) * | 1996-06-03 | 1997-12-30 | Uniroyal Chemical Company, Inc. | Removal of unreacted diisocyanate monomer from polyurethane prepolymers |
| SE510868C2 (sv) * | 1997-11-03 | 1999-07-05 | Artimplant Dev Artdev Ab | Formkroppar för användning som implantat i humanmedicin samt förfarande för framställning av sådana formkroppar |
-
1999
- 1999-06-04 ID IDW20010014A patent/ID28196A/id unknown
- 1999-06-04 AT AT99939800T patent/ATE254636T1/de active
- 1999-06-04 CA CA2334110A patent/CA2334110C/en not_active Expired - Lifetime
- 1999-06-04 AU AU42932/99A patent/AU756740B2/en not_active Expired
- 1999-06-04 US US09/701,622 patent/US6784273B1/en not_active Expired - Lifetime
- 1999-06-04 NZ NZ50890799A patent/NZ508907A/xx not_active IP Right Cessation
- 1999-06-04 EP EP02080448A patent/EP1308473A1/en not_active Withdrawn
- 1999-06-04 JP JP2000553492A patent/JP4335448B2/ja not_active Expired - Lifetime
- 1999-06-04 ES ES99939800T patent/ES2212602T3/es not_active Expired - Lifetime
- 1999-06-04 IL IL14004999A patent/IL140049A0/xx active IP Right Grant
- 1999-06-04 DE DE69912956T patent/DE69912956T2/de not_active Expired - Lifetime
- 1999-06-04 EP EP99939800A patent/EP1093483B1/en not_active Expired - Lifetime
- 1999-06-04 WO PCT/NL1999/000352 patent/WO1999064491A1/en not_active Ceased
- 1999-06-04 BR BRPI9910968-9A patent/BR9910968B1/pt not_active IP Right Cessation
-
2000
- 2000-12-03 IL IL140049A patent/IL140049A/en not_active IP Right Cessation
- 2000-12-05 NO NO20006180A patent/NO332315B1/no not_active IP Right Cessation
- 2000-12-13 ZA ZA200007439A patent/ZA200007439B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999064491A1 (en) | 1999-12-16 |
| US6784273B1 (en) | 2004-08-31 |
| BR9910968B1 (pt) | 2009-05-05 |
| EP1093483A1 (en) | 2001-04-25 |
| DE69912956T2 (de) | 2004-11-11 |
| EP1308473A1 (en) | 2003-05-07 |
| ES2212602T3 (es) | 2004-07-16 |
| JP2002517577A (ja) | 2002-06-18 |
| IL140049A (en) | 2008-03-20 |
| CA2334110C (en) | 2011-09-20 |
| CA2334110A1 (en) | 1999-12-16 |
| JP4335448B2 (ja) | 2009-09-30 |
| IL140049A0 (en) | 2002-02-10 |
| ZA200007439B (en) | 2001-08-08 |
| NZ508907A (en) | 2004-12-24 |
| BR9910968A (pt) | 2001-02-13 |
| ATE254636T1 (de) | 2003-12-15 |
| AU756740B2 (en) | 2003-01-23 |
| ID28196A (id) | 2001-05-10 |
| NO20006180L (no) | 2001-01-22 |
| AU4293299A (en) | 1999-12-30 |
| NO20006180D0 (no) | 2000-12-05 |
| EP1093483B1 (en) | 2003-11-19 |
| DE69912956D1 (de) | 2003-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO332315B1 (no) | Bionedbrytbar biomedisinsk polyuretan med faseseparert morfologi, fremgangsmate for fremstilling derav og anvendelse derav i menisk rekonstruksjon | |
| EP1138336B1 (en) | Biomedical polyurethane-amide, its preparation and use | |
| Ng et al. | Preparation and modification of water-blown porous biodegradable polyurethane foams with palm oil-based polyester polyol | |
| AU2008307139B2 (en) | High modulus polyurethane and polyurethane/urea compositions | |
| Marcos-Fernández et al. | Synthesis and characterization of biodegradable non-toxic poly (ester-urethane-urea) s based on poly (ε-caprolactone) and amino acid derivatives | |
| CN1950098B (zh) | 生物可降解聚氨酯和聚氨酯脲 | |
| US6087465A (en) | Melt-processible poly (ester urethane) and a process for the preparation thereof | |
| Spaans et al. | High molecular weight polyurethanes and a polyurethane urea based on 1, 4-butanediisocyanate | |
| JP2002517577A5 (https=) | ||
| De Groot et al. | On the role of aminolysis and transesterification in the synthesis of ɛ-caprolactone and L-lactide based polyurethanes | |
| EP1594908B1 (en) | Method for the preparation of new segmented polyurethanes with high tear and tensile strengths and method for making porous scaffolds | |
| CN109310802B (zh) | 改进的生物医学聚氨基甲酸酯 | |
| EP2027173A1 (en) | Biodegradable polyurethanes | |
| WO2016135349A1 (en) | Phase segregated block copolymers with tunable properties | |
| CN112194781A (zh) | 一种由乙醇酸制备聚酯多元醇的方法 | |
| Izadi-Vasafi et al. | A novel biodegradable polyurethane based on hydroxylated polylactic acid and tung oil mixtures. I. Synthesis, physicochemical and biodegradability characterization | |
| JP2008120888A (ja) | 生分解性共重合体及びその製造方法 | |
| WO2014004334A1 (en) | Process for making biodegradable and/or bioabsorbable polymers | |
| AU2005223917A1 (en) | Biodegradable polyurethane and polyurethane ureas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: POLYGANICS IP BV, NL |
|
| MK1K | Patent expired |